BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 14, 2011
View Archived Issues
Phase I/II trials assess safety and immunogenicity of HIV vaccine F4/AS01
Read More
ATX-101 potentiates activity of chemotherapy in preclinical studies by disrupting cell cycle control
Read More
Phase I data support safety and tolerability of YH-4808 in healthy subjects
Read More
Vifor reports new hepcidin antagonists for treatment of anemia
Read More
Ambit Biosciences presents new tyrosine-protein kinase inhibitors
Read More
German researchers present novel agents for HIV
Read More
PET tracer [18F]-MK-3328 shows favorable pharmacological profile and promise in Alzheimer's disease
Read More
Kyowa Hakko Kirin begins phase III pegfilgrastim study in Japan
Read More
Novel activators of the K(Ca)2.3 channel synthesized by RaQualia researchers
Read More
Jasco Pharma and North Carolina Central University form research program
Read More
AFFiRiS' AD-02 Alzheimer's disease vaccine shows potential in phase I trial
Read More
Galapagos' GLPG-0187 enters phase Ib trial in patients with solid tumors
Read More
Oxford Vaccine Group receives grant from Action Medical Research to develop meningitis vaccine
Read More
Herceptin obtains additional approval in Japan for gastric cancer overexpressing HER2
Read More
Astellas files for Japanese approval of bixalomer for hyperphosphatemia
Read More
Janssen Pharma launches Stelara in Japan for psoriasis
Read More
Almirall launches Sativex in Spain for treatment of spasticity in MS
Read More
CTI gains rights to Chroma Therapeutics' antitumor drug tosedostat in the Americas
Read More
Collaboration established for research into beta-cell regeneration in diabetes
Read More
Phase III DEFEND-1 trial in type 1 diabetes does not meet primary endpoint
Read More
BioInvent advances phase II trial of cardiovascular drug candidate BI-204
Read More
Clinical evaluation of NVP-BKM-120 for treatment of endometrial and colorectal cancer under way
Read More
Phase I/II trial to assess safety/effectiveness of TRC-105 plus sorafenib in HCC is now recruiting
Read More
Preclinical anticancer activity supports entry of OCID-4681-S-01 in phase I trial in solid tumors
Read More
MRK-560 shows preference for PS-1-containing gamma-secretases
Read More